Literature DB >> 13625373

Mass treatment with pyrimethamine; a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952-September 1953.

S A JONES.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13625373     DOI： 10.1016/0035-9203(58)90104-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  8 in total

Review 1.  The changing limits and incidence of malaria in Africa: 1939-2009.

Authors:  Robert W Snow; Punam Amratia; Caroline W Kabaria; Abdisalan M Noor; Kevin Marsh
Journal:  Adv Parasitol       Date:  2012       Impact factor: 3.870

Review 2.  Resistance of Plasmodium falciparum.

Authors:  E B Doberstyn
Journal:  Experientia       Date:  1984-12-15

Review 3.  New answers through chemotherapy?

Authors:  W Peters
Journal:  Experientia       Date:  1984-12-15

Review 4.  Mass drug administration for malaria.

Authors:  Eugenie Poirot; Jacek Skarbinski; David Sinclair; S Patrick Kachur; Laurence Slutsker; Jimee Hwang
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

Review 5.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 6.  Mass drug administration for malaria.

Authors:  Monica P Shah; Jimee Hwang; Leslie Choi; Kim A Lindblade; S Patrick Kachur; Meghna Desai
Journal:  Cochrane Database Syst Rev       Date:  2021-09-29

7.  Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.

Authors:  Allen L Malisa; Richard J Pearce; Salim Abdulla; Hassan Mshinda; Patrick S Kachur; Peter Bloland; Cally Roper
Journal:  Malar J       Date:  2010-07-05       Impact factor: 2.979

8.  Mass drug administration can be a valuable addition to the malaria elimination toolbox.

Authors:  Thomas P Eisele
Journal:  Malar J       Date:  2019-08-22       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.